cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period
- 21 July 2012
- book chapter
- Published by Springer Nature
- Vol. 8, 57-62
Abstract
This study describes a cblE type of homocystinuria associated with haemolytic-uremic syndrome (HUS) features. We report on a male infant aged 43 days presenting with failure to thrive, hypotonia, pancytopaenia, HUS symptoms (microangiopathic haemolytic anaemia and thrombocytopaenia with signs of renal involvement) and fatal evolution. An underlying cobalamin disorder was diagnosed after a bone marrow examination revealed megaloblastic changes associated with hyperhomocysteinaemia. An urinary organic acid analysis revealed normal methylmalonic acid excretion. The cblE diagnosis was confirmed with a complementation analysis using skin fibroblasts and genetic studies of the MTRR gene. The patient treatment included parenteral hydroxocobalamin, carnitine, betaine and folinic acid, but there was no response. After the autopsy, the histopathological examination of the kidneys showed marked myointimal proliferation and narrowing of the vascular lumen. The central nervous system showed signs of haemorrhage that affected the putamen and the thalamus; diffuse white matter lesions with spongiosis, necrosis and severe astrogliosis were also observed. Microangiopathy was observed with an increase in vessel wall thickness, a reduction of the arterial inner diameter and capillary oedema. The signs of necrosis and haemorrhage were detected in the cerebellum, the cerebellar peduncles, the tegmentum and the bulbar olives. In conclusion, cblE should be considered when diagnosing patients presenting with HUS signs and symptoms during the newborn period. Despite early diagnosis, however, the specific treatment measures were not effective in this patient.Keywords
This publication has 23 references indexed in Scilit:
- Mikrozephalus und megaloblastäre Anämie als Leitsymptome einer seltenen angeborenen Störung des intrazellulären Kobalamin-Processings - 3 KasuistikenKlinische Padiatrie, 2007
- Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorderPediatric Nephrology, 2007
- Epidemiology, Clinical Presentation, and Pathophysiology of Atypical and Recurrent Hemolytic Uremic SyndromeSeminars in Thrombosis and Hemostasis, 2006
- cblEType of homocystinuria due to methionine synthase reductase deficiency: Functional correction by minigene expressionHuman Mutation, 2005
- Cobalamin C Disease Presenting as Hemolytic-Uremic Syndrome in the Neonatal PeriodJournal of Pediatric Hematology/Oncology, 2002
- Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.Journal of Clinical Investigation, 1993
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- Cobalamin C defect associated with hemolytic-uremic syndromeThe Journal of Pediatrics, 1992
- Vitamin B12-responsive megaloblastic anemia, homocystinuria, and transient methylmalonic aciduria in cbIE diseaseThe Journal of Pediatrics, 1988
- Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.Journal of Clinical Investigation, 1986